InsiderTrades

Form 4 for PFE Pfizer

Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-26 · accession 0001225208-22-003723 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-01 2022-02-26 PFE DAMELIO FRANK A EVP M - OptEx $25.60 +127.2K 649.9K +24% +$3.26M
DM 2022-03-01 2022-02-26 PFE DAMELIO FRANK A EVP F - Tax $49.56 -94.0K 555.9K -14% -$4.66M
D 2022-03-01 2022-02-26 PFE DAMELIO FRANK A EVP M - OptEx $0.00 -127.2K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-26 M A 127,160 $25.60 649,918 D — — (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
2 Common Common Stock 2022-02-26 F D 34,607 $47.72 615,311 D — — (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. (F3) Price is the closing price of Pfizer common stock on February 25, 2022.
3 Common Common Stock 2022-02-26 F D 59,370 $50.64 555,941 D — — (F4) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F5) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
4 Derivative Stock Appreciation Rights 2022-02-26 M D 127,160 $0.00 0 D $25.60 · 2022-02-26 to 2022-02-26 127,160 Common Stock